Statement of Organization, Functions, and Delegations of Authority, 37463-37464 [E8-14896]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 127 / Tuesday, July 1, 2008 / Notices
Dated: June 19, 2008.
Ivor A. Pritchard,
Acting Director, Office for Human Research
Protections.
[FR Doc. E8–14917 Filed 6–30–08; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration on Aging
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Extension
of Certification on Maintenance of
Effort for the Title III and Certification
of Long-Term Care Ombudsman
Program Expenditures
Administration on Aging, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: The Administration on Aging
(AoA) is announcing that the proposed
collection of information listed below
has been submitted to the Office of
Management and Budget (OMB) for
review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Submit written comments on the
collection of information by July 31,
2008.
Submit written comments
on the collection of information by fax
202.395.6974 to the OMB Desk Officer
for AoA, Office of Information and
Regulatory Affairs, OMB.
FOR FURTHER INFORMATION CONTACT:
Rodd Clay, e-mail:
rodd.clay@aoa.hhs.gov.
ADDRESSES:
In
compliance with 44 U.S.C. 3507, AoA
has submitted the following proposed
collection of information to OMB for
review and clearance. With respect to
the following collection of information,
AoA invites comments on: (1) Whether
the proposed collection of information
is necessary for the proper performance
of AoA’s functions, including whether
the information will have practical
utility; (2) the accuracy of AoA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques
when appropriate, and other forms of
information technology.
The Certification on Maintenance of
Effort for the Title III and Certification
sroberts on PROD1PC70 with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Aug<31>2005
21:01 Jun 30, 2008
Jkt 214001
of Long-Term Care Ombudsman
Program Expenditures provides
statutorily required information
regarding state’s contribution to
programs funded under the Older
Americans Act and conformance with
legislative requirements, pertinent
Federal regulations and other applicable
instructions and guidelines issued by
Administration on Aging (AoA). This
information will be used for Federal
oversight of Title III Programs and Title
VII Ombudsman Program.
AoA estimates the burden of this
collection of information as follows: 56
State Agencies on Aging respond
annually which should be an average
burden of one half (1⁄2) hour per State
agency per year or a total of twentyeight hours for all state agencies
annually. In the Federal Register of
March 19, 2008 (Vol. 73, No. 54 Page
14821), the agency requested comments
on the proposed collection of
information. No comments on the
content of the collection were received.
Dated: June 26, 2008.
Josefina G. Carbonell,
Assistant Secretary for Aging.
[FR Doc. E8–14898 Filed 6–30–08; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Statement of Organization, Functions,
and Delegations of Authority
Part F of the Statement of
Organization, Functions, and
Delegations of Authority for the
Department of Health and Human
Services, Centers for Medicare &
Medicaid Services (CMS), (Federal
Register , Vol. 73, No. 46, pp. 12451–
12452, dated Friday, March 7, 2008) is
amended to reflect a change in the name
and updates to the functions for the
Center for Beneficiary Choices.
Part F. is described below:
• Section F. 20. (Functions) reads as
follows:
Center for Drug and Health Plan Choice
(FAE)
• Responsible for all national policies
and operations necessary for the
purchasing of Medicare Prescription
Drug (Part D) and Medicare Advantage
(Part C) health plan benefits. Designs,
implements, and manages the
procurement of prescription drug plans
(PDPs) and Medicare Advantage plans
(MA and MA–PD plans), including the
solicitation and approval of
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
37463
applications, review of benefits and
negotiation of competitive bids, the
implementation of quality improvement
and performance measures, review of
fiscal solvency and contractor
management activities.
• Develops and improves all bidding
and payment policies related to the
Medicare Prescription Drug Benefit and
the Medicare Advantage (MA) program.
• Validates payments to the Part D
prescription drug and MA plans,
including routine annual risk
adjustment data validation based on
medical record review.
• Coordinates the development and
management of business requirements
for the national systems for enrollment,
payment, and contractor management
for the Prescription Drug Benefit and the
Medicare Advantage (MA) programs.
• Develops and implements the
national policy and oversees operational
implementation for all issues related to
the Retiree Drug Subsidy Program.
• Develops national policy for
eligibility, enrollment and entitlement
for Medicare Parts A, B, C, and D,
including oversight of activities related
to Part D auto-enrollment, low income
subsidy, and creditable coverage.
• Develops national policy and
oversees operational activities related to
Medicare Part A, B, C, and D claimsrelated hearings, appeals, grievances
and other beneficiary-centered dispute
resolution processes.
• Serves as the focal point for issues
related to a variety of Federal standards
affecting private health insurance
coverage, including those pertaining to
its administration of the Medigap
program, Title I of the Health Insurance
Portability and Accountability Act and
the Consolidated Omnibus Budget
Reconciliation Act.
• Works closely with the regional
Consortium for Medicare Health Plans
Operations (CMHPO) on all operational
aspects of the Part C and Part D
programs.
• Develops and implements Part C
and Part D contractor performance
monitoring programs and Part C and
Part D compliance and oversight
programs and carries out these programs
collaboratively with CMHPO.
• Develops surveys to measure
consumer experiences with their health
plans and health care providers;
manages the Consumer Assessment of
Health Care Provider and Systems
(CAHPS) survey; develops and prepares
performance measures for Part C
sponsors; analyzes and reports Health
Plan Employers Data and Information
Set data for Part C performance
measures and consumer reports; and
E:\FR\FM\01JYN1.SGM
01JYN1
37464
Federal Register / Vol. 73, No. 127 / Tuesday, July 1, 2008 / Notices
assesses the effectiveness of CMS’
quality reporting activities.
• Effectively communicates program
policies related to the Prescription Drug
and Medicare Advantage (MA) programs
to heath plans and drug plan
contractors, employer group sponsors,
beneficiary advocates and other
stakeholders in the health care field.
• Develops new policies (e.g. health
plan access, benefits, special needs
plans) and programs to reflect changes
in program objectives, the health care
delivery system, beneficiary health care
needs, and new plan types to support an
appropriate range of choices for
beneficiaries.
• Collaborates with our partners, such
as industry, other government entities
and advocacy groups, to understand
their perspectives on Prescription Drug
and Medicare Managed Care policies
and procedures and to drive best
practices in the health care industry.
• Develops and implements a
comprehensive strategic plan, objectives
and measures for overseeing an effective
compliance and oversight program for
all Part C (Medicare Advantage) and
Part D (Medicare Prescription Drug)
contractors in close collaboration with
CMHPO, the Medicare Drug Benefit and
C & D Data Group, the Medicare Drug
and Health Plan Contract
Administration Group and other Center
for Drug and Health Plan Choice
components.
• Develops and implements a
comprehensive and effective audit
program for all Part C (Medicare
Advantage) and Part D (Medicare
Prescription Drug) contractors.
Dated: June 21, 2008.
James W. Weber,
Acting Director, Office of Operations
Management, Centers for Medicare &
Medicaid Services.
[FR Doc. E8–14896 Filed 6–30–08; 8:45 am]
sroberts on PROD1PC70 with NOTICES
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
[Docket No. FDA–2008–N–0354]
[Docket No. FDA–2004–N–0188] (formerly
Docket No. 2004N–0081)
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Request for Designation as Country
Not Subject to the Restrictions
Applicable to Human Food and
Cosmetics Manufactured From,
Processed With, or Otherwise
Containing, Material From Cattle
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Request for Designation as Country not
Subject to the Restrictions Applicable to
Human Food and Cosmetics
Manufactured from, Processed With, or
Otherwise Containing, Material from
Cattle’’ has been approved by the Office
of Management and Budget (OMB)
under the Paperwork Reduction Act of
1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
In the
Federal Register of April 17, 2008 (73
FR 20785), the agency announced that
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0623. The
approval expires on June 30, 2011. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
SUPPLEMENTARY INFORMATION:
Dated: June 24, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–14882 Filed 6–30–08; 8:45 am]
BILLING CODE 4160–01–S
VerDate Aug<31>2005
21:01 Jun 30, 2008
Jkt 214001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Mental Models
Study of Farmers’ Understanding and
Implementation of Good Agricultural
Practices
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the proposed study entitled ‘‘Mental
Models Study of Farmers’
Understanding and Implementation of
Good Agricultural Practices.’’
DATES: Submit written or electronic
comments on the collection of
information by September 2, 2008.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
E:\FR\FM\01JYN1.SGM
01JYN1
]]>Agencies
[Federal Register Volume 73, Number 127 (Tuesday, July 1, 2008)]
[Notices]
[Pages 37463-37464]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14896]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
Statement of Organization, Functions, and Delegations of
Authority
Part F of the Statement of Organization, Functions, and Delegations
of Authority for the Department of Health and Human Services, Centers
for Medicare & Medicaid Services (CMS), (Federal Register , Vol. 73,
No. 46, pp. 12451-12452, dated Friday, March 7, 2008) is amended to
reflect a change in the name and updates to the functions for the
Center for Beneficiary Choices.
Part F. is described below:
Section F. 20. (Functions) reads as follows:
Center for Drug and Health Plan Choice (FAE)
Responsible for all national policies and operations
necessary for the purchasing of Medicare Prescription Drug (Part D) and
Medicare Advantage (Part C) health plan benefits. Designs, implements,
and manages the procurement of prescription drug plans (PDPs) and
Medicare Advantage plans (MA and MA-PD plans), including the
solicitation and approval of applications, review of benefits and
negotiation of competitive bids, the implementation of quality
improvement and performance measures, review of fiscal solvency and
contractor management activities.
Develops and improves all bidding and payment policies
related to the Medicare Prescription Drug Benefit and the Medicare
Advantage (MA) program.
Validates payments to the Part D prescription drug and MA
plans, including routine annual risk adjustment data validation based
on medical record review.
Coordinates the development and management of business
requirements for the national systems for enrollment, payment, and
contractor management for the Prescription Drug Benefit and the
Medicare Advantage (MA) programs.
Develops and implements the national policy and oversees
operational implementation for all issues related to the Retiree Drug
Subsidy Program.
Develops national policy for eligibility, enrollment and
entitlement for Medicare Parts A, B, C, and D, including oversight of
activities related to Part D auto-enrollment, low income subsidy, and
creditable coverage.
Develops national policy and oversees operational
activities related to Medicare Part A, B, C, and D claims-related
hearings, appeals, grievances and other beneficiary-centered dispute
resolution processes.
Serves as the focal point for issues related to a variety
of Federal standards affecting private health insurance coverage,
including those pertaining to its administration of the Medigap
program, Title I of the Health Insurance Portability and Accountability
Act and the Consolidated Omnibus Budget Reconciliation Act.
Works closely with the regional Consortium for Medicare
Health Plans Operations (CMHPO) on all operational aspects of the Part
C and Part D programs.
Develops and implements Part C and Part D contractor
performance monitoring programs and Part C and Part D compliance and
oversight programs and carries out these programs collaboratively with
CMHPO.
Develops surveys to measure consumer experiences with
their health plans and health care providers; manages the Consumer
Assessment of Health Care Provider and Systems (CAHPS) survey; develops
and prepares performance measures for Part C sponsors; analyzes and
reports Health Plan Employers Data and Information Set data for Part C
performance measures and consumer reports; and
[[Page 37464]]
assesses the effectiveness of CMS' quality reporting activities.
Effectively communicates program policies related to the
Prescription Drug and Medicare Advantage (MA) programs to heath plans
and drug plan contractors, employer group sponsors, beneficiary
advocates and other stakeholders in the health care field.
Develops new policies (e.g. health plan access, benefits,
special needs plans) and programs to reflect changes in program
objectives, the health care delivery system, beneficiary health care
needs, and new plan types to support an appropriate range of choices
for beneficiaries.
Collaborates with our partners, such as industry, other
government entities and advocacy groups, to understand their
perspectives on Prescription Drug and Medicare Managed Care policies
and procedures and to drive best practices in the health care industry.
Develops and implements a comprehensive strategic plan,
objectives and measures for overseeing an effective compliance and
oversight program for all Part C (Medicare Advantage) and Part D
(Medicare Prescription Drug) contractors in close collaboration with
CMHPO, the Medicare Drug Benefit and C & D Data Group, the Medicare
Drug and Health Plan Contract Administration Group and other Center for
Drug and Health Plan Choice components.
Develops and implements a comprehensive and effective
audit program for all Part C (Medicare Advantage) and Part D (Medicare
Prescription Drug) contractors.
Dated: June 21, 2008.
James W. Weber,
Acting Director, Office of Operations Management, Centers for Medicare
& Medicaid Services.
[FR Doc. E8-14896 Filed 6-30-08; 8:45 am]
BILLING CODE 4120-01-P
